The Threat of Self-Spreading Vaccines
It may sound like the plot of a science fiction movie, but U.S. National Institutes of Health (NIH) funded scientists have been secretly working on genetically-engineered live virus vaccines, which they refer to as “contagious” vaccines, that can transmit vaccine strain viruses through a population on their own. The vaccines are so contagious that only […]
More Than 82 Million Doses of COVID-19 Shots Discarded in U.S. Due to Low Demand
The U.S. Centers for Control and Disease Prevention (CDC) said that pharmacies, state health authorities and federal agencies in the United States discarded 82.1 million doses of COVID-19 shots between December 2020 and May 2022. The discarded doses equate to over 11 percent of the COVID vaccine doses the U.S. government distributed across the country.1 […]
FDA Panel Recommends EUA for Novavax COVID-19 Vaccine
Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]
FDA Approves Fourth COVID Shot. Fifth Shot Considered.
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]
Harvard Study’s Goal: Identifying Messages That ‘Break Through’ to Vaccine Skeptics
“If only there were a message that could break through skepticism and persuade unvaccinated people to get their shots. What a world that would be. But over the past year, this really did happen,” reads a February 2022 Vox article1 that continues on to describe a Harvard Business School publication2 which offers new evidence on […]
